CDK9 and acute myeloid leukemia: CDK9 promotes transcription of genes encoding prosurvival factors, including c-Myc, which plays a critical role in leukemogenesis and drug resistance in AML.22,28,29 Thus, CDK9 inhibition may downregulate c-Myc, leading to enhancement of apoptosis induced by venetoclax.